WO2015005928A1 - Analytical method for detecting sulfated oligosaccharides - Google Patents

Analytical method for detecting sulfated oligosaccharides Download PDF

Info

Publication number
WO2015005928A1
WO2015005928A1 PCT/US2013/050147 US2013050147W WO2015005928A1 WO 2015005928 A1 WO2015005928 A1 WO 2015005928A1 US 2013050147 W US2013050147 W US 2013050147W WO 2015005928 A1 WO2015005928 A1 WO 2015005928A1
Authority
WO
WIPO (PCT)
Prior art keywords
mobile phase
hilic
poly
column
salt
Prior art date
Application number
PCT/US2013/050147
Other languages
French (fr)
Inventor
Helen CHAO
ChungYao WANG
Imin HUANG
ChiaYen WU
YungTe CHIANG
Original Assignee
Scinopharm Taiwan, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Taiwan, Ltd. filed Critical Scinopharm Taiwan, Ltd.
Priority to CA2917460A priority Critical patent/CA2917460A1/en
Priority to CN201380078160.1A priority patent/CN105431733B/en
Priority to AU2013393832A priority patent/AU2013393832B2/en
Priority to JP2016525337A priority patent/JP6208866B2/en
Priority to PCT/US2013/050147 priority patent/WO2015005928A1/en
Priority to KR1020167003059A priority patent/KR20160030963A/en
Priority to EP13888999.3A priority patent/EP3019861A4/en
Publication of WO2015005928A1 publication Critical patent/WO2015005928A1/en
Priority to IL243405A priority patent/IL243405A0/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/30Partition chromatography
    • B01D15/305Hydrophilic interaction chromatography [HILIC]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8836Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph

Definitions

  • Heparnoid Heparin and Heparan sulfate
  • LMWH low-molecular weight heparin
  • Fondaparinux sodium CAS 1 14870-03-0
  • CAS 1 14870-03-0 is a member of
  • oligosaccharides / heparins with a chemical name of 0-[2-Deoxy-6-0-sulfo-2-(su!foamino)- alpha-D-glucopyranosyl]-( 1 ⁇ 4)-0-(beta-D-glucopyranurosonyl)-( 1 -4)-0-[2-deoxy-3,6-di-0- sulfb-2-(sulfoaminc -aipha. ⁇ D-g]u ⁇
  • Catalan et al. ( Anal Chem. 2009, 81, 3485) and Tatiana et al, ( Anal Chem. 2006, 78, 1774) have each described the characterization of poly-sulfated oligosaccharides by using electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption and ionization mass spectrometry (MALDI-MS).
  • ESI-MS electrospray ionization mass spectrometry
  • MALDI-MS matrix-assisted laser desorption and ionization mass spectrometry
  • oligosaccharides are due to the non-chromophore characteristics (very low UV absorption) of poly-sulfated oligosaccharides, which can restrict the use of traditional UV detectors.
  • the other universal detectors such as refractive index (RI) and evaporative light scattering (ELSD) also lack enough detecting sensitivity for poly-sulfate oligosaccharides.
  • RI refractive index
  • ELSD evaporative light scattering
  • HILIC-UPLC hydrophilic interaction ultra-performance liquid chromatography
  • CAD charged aerosol detector
  • MS mass spectrometer
  • HILIC overcomes the challenge of retaining and separating extremely polar oligosaccharides.
  • the retention mechanism for HILIC is very intricate and is a multi-modal combination of liquid-liquid partitioning, adsorption, ionic interaction and hydrophobic interaction. Therefore, HILIC, in comparison to reverse phase liquid chromatography (RPLC), provides unique selectivity and retention characteristics,
  • the stationary phase used in HILIC column is, in one group of embodiments, an amide-bonded stationary phase.
  • the mobile phase used in HILIC column comprises a salt, in one group of embodiments, the salt is ammonium formate.
  • the concentration of the salt is higher than 50 mM. In some selected embodiments, the concentration is higher than 100 mM.
  • the molar strength of the salt additive in the mobile phase composition can have a significant impact on
  • the solvent of the mobile phase used in the HILIC column is acetonitriie.
  • the detector used for the quantitation of poly-sulfated oligosaccharides is a charged aerosol detector (CAD).
  • CAD charged aerosol detector
  • aerosol particles are charged with an ionized gas (typically nitrogen). After the removal of high-mobility particles (mainly excess N 2 ions), the aerosol particles are then electrically measured. Most importantly, the method has been demonstrated to provide a uniform response for nonvolatile analytes independent of their nature.
  • a separation technique utilizing HILIC, or HILIC-UPLC and (2) a detection technique such as MS or CAD allows for detection, identification and/or quantification of poly-sulfated thereby providing an effective way for analysis of synthetic poly-sulfated oligosaccharides.
  • the poly-sulfated oilgosaccharide detected and/or quantitated by the methods described herein is Fondaparinux sodium.
  • Figure 1(a) provides the chromatograms of HiLIC-CAD for Fondaparinux Sodium using Merck, Sequant Zic®-Hilic (3. Sum 2.1 x250mm).
  • Figure 1(b) provides the chromatograms of HILIC-C AD for Fondaparinux Sodium using Merck, Sequant Zic®-pHiiic (Sum 4.6x 150mm).
  • Figure 1(c) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Phenomenex, Synergi Polar-RP (4ura 4.6x250mm).
  • Figure 1(d) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Phenomenex, Synergi Fusion-RP (4um 4.6x150mm).
  • Figure 1(e) provide the chromatograms of HI LIC-CAD for Fondaparinux Sodium using Sepax Polar-Pyridine (1.8um 2.1 x 150mm).
  • Figure 1(f) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using ES, Epic Dio! (1 Jurn 2.1 ⁇ 150mm),
  • Figure 1(g) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Waters, Acquity BEH HILIC (1.7urn 2.1 x 150mm).
  • Figure 1(h) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Waters, Acquity BEH Amide (1.7um 2, l x 150mm).
  • Figure 2 provides the chromatogram for Fondaparinux Sodium using Waters, BEH .Amide column (a) full scale and (b) expanded scale.
  • Figure 3 provides the chromatograms in expanded scale of the drug substance analyzed using different types of salt (a) 50 niM ammonium formate (b) 100 mM ammonium formate (c) 100 mM pyridinium formate and (d) 50 mM ammonium acetate
  • Figure 4 provides the chromatograms in expanded scale of the drag substance analyzed using various concentrations of ammonium formate (in expanded scale) (a) 50 mM (b) 100 mM (c) 125 mM (d) 1 50 mM (e) 175 mM and (f) 200 mM.
  • Figure 5 provides the chromatograms in expanded scale of the drug substance analyzed using different organic solvents to be mobile phase (a) mobile phase A: 200 mM ammonium formate; mobile phase B: acetone and acetonitrile, 1/1 (b) mobile phase A: 200 mM ammonium formate; mobile phase B: acetonitrile.
  • IPC in-process control
  • H1 L1C column (a) subjecting said sample to chromatography on a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) column coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS), wherein the stationary phase used in H1 L1C column is an amide- bonded stationary phase; and
  • HILIC-UPLC hydrophilic interaction ultra-performance liquid chromatography
  • CAD charged aerosol detector
  • MS mass spectrometer
  • the samples used in the present methods are typically the output of synthetic production methods of poly-sulfated oligosaccharides.
  • samples of the final step in the synthetic procedures can be analyzed according to the present methods by selecting aliquots of reaction mixtures. The sampling of reaction mixtures allows for detection and/or
  • the sampling of reaction mixture also allows for determination of the extent of completion of a reaction.
  • the final product can be subjected to the present methods to determine if further purification is needed,
  • the conditions for chromatography using hydrophilic interaction ultra-performance liquid chromatography wi ll generally involve those conditions known to one of skill in the art, including, but not limited to column selection (size, length and stationary phase) as well as the mobile phase and/or pH of the mobile phase.
  • the column has a stationary phase of neutral charge (e.g., diol phase or amide phase), a charged stationary phase (e.g., silica phase, aminopropyl phase), or a zwitterionic stationary phase.
  • the stationary phase is an amide-bonded stationary phase. Examples 1 - 10 illustrate the results obtained from the use of various stationary phases using the methods described herein.
  • the solvent used in the mob le phase is generally a polar, aprotic organic solvent or a mixture of polar, aprotic organic solvents.
  • the solvent of the mobile phase used in HTL!C column is acetonitrile, acetone or a mixture of acetonitrile and acetone.
  • Examples 13a- 13d illustrate the effect of various solvents and/or mixtures of solvents in the detection and/or quantitation of poly-sulfated oligosaccharides using the methods described herein.
  • the mobile phase will also comprise a salt, generally a salt selected from ammonium formate, pyridimum formate and ammonium acetate, and mixtures thereof.
  • the mobile phase will comprise ammonium formate.
  • the mobile phase comprises a salt selected from ammonium citrate and/or ammonium oxalate. Examples 1 la-1 Id iiiustrate the effect of various salts in the mobi le phase in the detection and/or quantitation of poly-sulfated oligosaccharides using the methods described herein.
  • the concentration of the salt used in the mobile phase will generally be from 25 to about 400 mM, though some optimal results are found when the salt is present in the mobile phase at concentrations of from 50 to about 200 mM. in some embodiments, the salt is present in the mobile phase at concentrations of about 50-100 mM, from about 100-200 mM, and from about 75 to 175 mM.
  • Examples I2a ⁇ 12d illustrate the effect of various salt concentrations on peak resolution and peak width during the detection and/or quantitation of poly-sulfated oligosaccharides, when using the methods described herein, by employing ammonium formate as the salt,
  • the methods described above are useful for detection and/or quantitation of the poly-sulfated oligosaccharide fondaparinux having the structure:
  • a method for detecting and quantitating fondaparinux in a sample comprising:
  • HILIC-UPLC hydrophilic interaction ultra- performance liquid chromatography
  • CAD charged aerosol detector
  • MS mass spectrometer
  • chromatograms using the methods described herein (e.g., by use of HILIC-UPLC") and peak identification using a coupled techinque such as CAD or MS thereby confirming (detecting) the presence or absence of tbndaparinux and/or impurities in the sample.
  • a coupled techinque such as CAD or MS
  • the instruments involved in UPLC-MS study are Ultimate 3000 (UPLC) and micrOTOF-Q ⁇ TM (MS) which were manufactured by Thermo Fisher Dionex and Bruker Daltonics, respectively.
  • the instruments involved in UPLC-CAD are ACQUITY UPLC® System and Thermo Scientific Dionex Ultra CAD which were manufactured by Waters Corporation and Thermo Fisher Dionex, respectively.
  • the concentration of ammonium formate used in the mobile phase is 100 mM or higher than 100 mM.
  • the volume proportion of ammonium formate : acetonitrile in the mobile phase composition is in the range of 95% - 5% ; 5% - 95%.
  • the concentration of testing sample is from 15 ,ug/rnL to 30 mg/mL.
  • the injection volume of testing sample is from 1 ⁇ to 5 uL.
  • Examples 13a and 13b use the mixtures of acetonitrile and acetone and acetonitrile respectively as the solvent of the mobile phase for analyzing Fondaparinux Sodium according to the present invention.
  • the results shown in Figure 5 indicate no obvious difference in selectivity between acetonitrile system and mixture (acetonitrile and acetone) system, a higher back pressure was observed in the system comprising the acetone/acetonitrile mixture than in the acetonitrile system.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)

Abstract

The present invention describes an analytical method for detecting and quantitating poly-sulfated oligosaccharides, including Fondaparinux sodium, using hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS). This analytical method provides in-process control in a total synthesis of highly sulfated oligosaccharides by separation, quantification and mass identification. Systems and conditions utilizing such methods are also provided.

Description

ANALYTICAL METHOD FOR DETECTING SULFATED
OLIGOSACCHARIDES
CROSS-REFERENCES TO RELATED APPLICATIONS [0001] Not Applicable
BACKGROUND OF THE INVENTION
[0002] Heparnoid (Heparin and Heparan sulfate) is a well-known regulatory mediator in numerous important biological processes, Heparnoid and its derivative, low-molecular weight heparin (LMWH), have been used as clinical anticoagulant drugs during surgery and kidney dialysis. For example, Fondaparinux sodium (CAS 1 14870-03-0) is a member of
oligosaccharides / heparins with a chemical name of 0-[2-Deoxy-6-0-sulfo-2-(su!foamino)- alpha-D-glucopyranosyl]-( 1 ~4)-0-(beta-D-glucopyranurosonyl)-( 1 -4)-0-[2-deoxy-3,6-di-0- sulfb-2-(sulfoaminc -aipha.~D-g]u^
(l ~-4)-0-[2-deoxy-l-0-methyl-6-0-suifo-2»(sulfoamino)-aipha-D-glucopyranoside] decasodium salt, and was developed by Choay, S.A. (see U.S. Patent No. 4,818,816). The compound is a synthetic pentasaccharide Factor Xa inhibitor which is used as an anticoagulant drug for the prevention of deep vein thrombosis in patients who have had orthopedic surgery as well as for the treatment of deep vein thrombosis and pulmonary embolism. Fondaparinux sodium was approved b the United States Food and Drug Administration in 2001 , marketed under the trade name Arixtra™. Fondaparinux sodium is administrated subcutaneously,
[0003] Analytical methods for heparin and heparan sulfate, traditionally involved reverse phase chromatographic and mass spectronietric (MS) techniques, but have limitations due to the high polarity, structural diversity, and sulfate lability of heparan sulfate. For instance, the quantitation of synthetic poly-sulfated oligosaccharides using MS is restricted because the ionization of poly-sulfated oligosaccharides tends to form various types of fragments and metal cation-coupled add acts with loss of sulfate groups. This leads to greater spectral complexity and signal splitting, in addition, it is difficult to demonstrate the degree of loss of sulfate groups during the analysis because it depends on the concentration and charge state of sulfated oligosaccharides. Improved analytical methods for poly-sulfated oligosaccharides have been the target of a number of research groups.
[0004] Catalan et al. ( Anal Chem. 2009, 81, 3485) and Tatiana et al, ( Anal Chem. 2006, 78, 1774) have each described the characterization of poly-sulfated oligosaccharides by using electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption and ionization mass spectrometry (MALDI-MS). However, the current methods using the coupling of liquid chromatograph (LC) with mass spectrometry does not provide on-line in-process resolution/separation of peaks and hence the identification of the structure related impurities and/or quantitation of the poly-sulfated oligosaccharides cannot be established during the production of synthetic poly-sulfated oligosaccharides.
[00053 Imanari et al. ( J. Chromatogr., A 1996,720, 275.) and Rice et al. ( J. Anal Biochem, 1985, 150, 325.) illustrated the analytical method of poly-sulfated oligosaccharides by strong anion exchange chromatography (SAX). This method appears to separate highly sulfated oligosaccharides via the difference in charge density, but it remains difficult to directly couple SAX with a detection method like MS due to the use of nonvolatile salt in the mobile phase composition. [0006] Still other problems associated with analytical methods for poly-sulfated
oligosaccharides are due to the non-chromophore characteristics (very low UV absorption) of poly-sulfated oligosaccharides, which can restrict the use of traditional UV detectors. The other universal detectors such as refractive index (RI) and evaporative light scattering (ELSD) also lack enough detecting sensitivity for poly-sulfate oligosaccharides. [0007] Although some methods of detection of poly-sulfated oligosaccharides have been disclosed, a number of limitations remain. Thus, there is a continuing need for improved methods for the separation, quantitation and mass identifica ion of poly-sulfated
oligosaccharides. The stable, sensitive and in-process control (IPC) methods disclosed herein address this need and other needs. BRIEF SUMMARY OF THE INVENTION
{0008] Provided herein is a method for detecting poly-sulfated oligosaccharides, using a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS). The methods provided herein allow for improved peak resolution thereby allowing for subsequent quantitation of poly-sulfated oligosaccharides and/or impurities in the sample.
[0009] The use of HILIC overcomes the challenge of retaining and separating extremely polar oligosaccharides. The retention mechanism for HILIC is very intricate and is a multi-modal combination of liquid-liquid partitioning, adsorption, ionic interaction and hydrophobic interaction. Therefore, HILIC, in comparison to reverse phase liquid chromatography (RPLC), provides unique selectivity and retention characteristics,
[0010] As provided herein, the stationary phase used in HILIC column is, in one group of embodiments, an amide-bonded stationary phase.
[0011] In another embodiment, the mobile phase used in HILIC column comprises a salt, in one group of embodiments, the salt is ammonium formate. The use of ammonium formate, in comparison to pyridinium formate and ammonium acetate, provides better performance for retention, selectivity and low noise level baseline. [0012] In some embodiments, the concentration of the salt is higher than 50 mM. In some selected embodiments, the concentration is higher than 100 mM. Typically, the molar strength of the salt additive in the mobile phase composition can have a significant impact on
chromatographic retention, selectivity and sensitivity. As the molarity of the salt additive increases, the ionic strength of the mobile phase and the solute is overpowered by the iiquid- liquid partitioning interaction which dominates the retention mechanism rather than the ion exchange effect. However, it has now been discovered that in the case of acidic analytes, such as poly-sulfated oligosaccharides, retention is enhanced as the molarity of the salt additive increases. In particular, the resolution of peaks is further improved as the salt concentration is increased from 50 mM to about 200 mM. [0013] In one group of embodiments, the solvent of the mobile phase used in the HILIC column is acetonitriie.
[0014] In some embodiments, the detector used for the quantitation of poly-sulfated oligosaccharides is a charged aerosol detector (CAD). During the analysis using CAD, aerosol particles are charged with an ionized gas (typically nitrogen). After the removal of high-mobility particles (mainly excess N2 ions), the aerosol particles are then electrically measured. Most importantly, the method has been demonstrated to provide a uniform response for nonvolatile analytes independent of their nature. Thus, the combination of (1.) a separation technique utilizing HILIC, or HILIC-UPLC, and (2) a detection technique such as MS or CAD allows for detection, identification and/or quantification of poly-sulfated thereby providing an effective way for analysis of synthetic poly-sulfated oligosaccharides.
[0015] in accordance with one selected embodiment of the present invention, the poly-sulfated oilgosaccharide detected and/or quantitated by the methods described herein is Fondaparinux sodium.
BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1(a) provides the chromatograms of HiLIC-CAD for Fondaparinux Sodium using Merck, Sequant Zic®-Hilic (3. Sum 2.1 x250mm). [0017] Figure 1(b) provides the chromatograms of HILIC-C AD for Fondaparinux Sodium using Merck, Sequant Zic®-pHiiic (Sum 4.6x 150mm).
[0018] Figure 1(c) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Phenomenex, Synergi Polar-RP (4ura 4.6x250mm).
[001 ] Figure 1(d) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Phenomenex, Synergi Fusion-RP (4um 4.6x150mm).
[0020] Figure 1(e) provide the chromatograms of HI LIC-CAD for Fondaparinux Sodium using Sepax Polar-Pyridine (1.8um 2.1 x 150mm). [0021] Figure 1(f) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using ES, Epic Dio! (1 Jurn 2.1 χ 150mm),
[0022] Figure 1(g) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Waters, Acquity BEH HILIC (1.7urn 2.1 x 150mm).
[0023] Figure 1(h) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Waters, Acquity BEH Amide (1.7um 2, l x 150mm).
(0024] Figure 2 provides the chromatogram for Fondaparinux Sodium using Waters, BEH .Amide column (a) full scale and (b) expanded scale.
[0025] Figure 3 provides the chromatograms in expanded scale of the drug substance analyzed using different types of salt (a) 50 niM ammonium formate (b) 100 mM ammonium formate (c) 100 mM pyridinium formate and (d) 50 mM ammonium acetate
[0026] Figure 4 provides the chromatograms in expanded scale of the drag substance analyzed using various concentrations of ammonium formate (in expanded scale) (a) 50 mM (b) 100 mM (c) 125 mM (d) 1 50 mM (e) 175 mM and (f) 200 mM.
[0027] Figure 5 provides the chromatograms in expanded scale of the drug substance analyzed using different organic solvents to be mobile phase (a) mobile phase A: 200 mM ammonium formate; mobile phase B: acetone and acetonitrile, 1/1 (b) mobile phase A: 200 mM ammonium formate; mobile phase B: acetonitrile.
DETAILED DESCRIPTION OF THE INVENTION
I. General
[0028] Provided herein is a straightforward in-process analytical method developed for poly- sulfated oligosaccharides involving the application of HILIC-UPLC, CAD and MS for separation, quantification and mass identification, respectively. The in-process control (IPC) during manufacturing is a key for ensuring quality control in a total synthesis of highly sulfated oligosaccharides. The analytical methods described herein are usable as IPC methods.
Advantageously, the analytical methods described herein are stable, easy to use, sensitive, and ensure the production of a quality chemical entity within the expected yields. II. Embodiments of the Invention
(0029] in view of the above, provided herein is method for detecting and quantitating one or more poly-sulfated oligosaccharides in a sample, the method comprising:
(a) subjecting said sample to chromatography on a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) column coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS), wherein the stationary phase used in H1 L1C column is an amide- bonded stationary phase; and
(b) determining the amount of poly-sulfated oligosaccharides in the sample.
[0030] The samples used in the present methods are typically the output of synthetic production methods of poly-sulfated oligosaccharides. As a result, samples of the final step in the synthetic procedures can be analyzed according to the present methods by selecting aliquots of reaction mixtures. The sampling of reaction mixtures allows for detection and/or
identification and/or quantitation of impurities and/or poly-sulfated oligosaccharides. The sampling of reaction mixture also allows for determination of the extent of completion of a reaction. Alternatively, the final product can be subjected to the present methods to determine if further purification is needed,
[0031] The conditions for chromatography using hydrophilic interaction ultra-performance liquid chromatography wi ll generally involve those conditions known to one of skill in the art, including, but not limited to column selection (size, length and stationary phase) as well as the mobile phase and/or pH of the mobile phase.
[0032] Selection of a column will generally involve selection from commercially prepared column such as those available from Waters, ThermoFisher, Merck, Phenomenex, Shodex, Nucleosil, and Sepax. in one group of embodiments, the column has a stationary phase of neutral charge (e.g., diol phase or amide phase), a charged stationary phase (e.g., silica phase, aminopropyl phase), or a zwitterionic stationary phase. In one selected group of embodiments, the stationary phase is an amide-bonded stationary phase. Examples 1 - 10 illustrate the results obtained from the use of various stationary phases using the methods described herein. [0033] One of skill in the art will appreciate that flow rates will also affect the separation and resolution obtained.
[0034] The solvent used in the mob le phase is generally a polar, aprotic organic solvent or a mixture of polar, aprotic organic solvents. In one group of embodiments, the solvent of the mobile phase used in HTL!C column is acetonitrile, acetone or a mixture of acetonitrile and acetone. Examples 13a- 13d illustrate the effect of various solvents and/or mixtures of solvents in the detection and/or quantitation of poly-sulfated oligosaccharides using the methods described herein.
[0035] In other embodiments, the mobile phase will also comprise a salt, generally a salt selected from ammonium formate, pyridimum formate and ammonium acetate, and mixtures thereof. In certain selected embodiments, the mobile phase will comprise ammonium formate. In an additional group of embodiments, the mobile phase comprises a salt selected from ammonium citrate and/or ammonium oxalate. Examples 1 la-1 Id iiiustrate the effect of various salts in the mobi le phase in the detection and/or quantitation of poly-sulfated oligosaccharides using the methods described herein.
[0036] The concentration of the salt used in the mobile phase will generally be from 25 to about 400 mM, though some optimal results are found when the salt is present in the mobile phase at concentrations of from 50 to about 200 mM. in some embodiments, the salt is present in the mobile phase at concentrations of about 50-100 mM, from about 100-200 mM, and from about 75 to 175 mM. Examples I2a~12d illustrate the effect of various salt concentrations on peak resolution and peak width during the detection and/or quantitation of poly-sulfated oligosaccharides, when using the methods described herein, by employing ammonium formate as the salt,
[0037] In specific embodiments, the methods described above are useful for detection and/or quantitation of the poly-sulfated oligosaccharide fondaparinux having the structure:
Figure imgf000009_0001
[003S] in another aspect, provided herein is a method for detecting and quantitating fondaparinux in a sample, the method comprising:
(a) subjecting said sample to chromatography on a hydrophilic interaction ultra- performance liquid chromatography (HILIC-UPLC) column coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS), wherein the stationary phase used in HILIC column is an amide-bonded stationary phase, the mobile phase used in said chromatography is acetonitrile, and the mobile phase comprises ammonium formate in a concentration of from about 100 m'M to about 200 raM; and
(b) determining the amount of fondaparinux in the sample
[0039] As used above and herein, "determination" of the amount of fondaparinux in the sample, or "quantitation of fondaparinux" is effected in one or more ways which are readily available to one of skill in the art. Generally, instruments for UPLC-MS - and/or CAD are sold with pre-installed programs and/or algorithms which can calculate the relative amounts of substances in a sample (e.g., by calculating the areas under the peaks and/or measuring relative intensities of peaks). According to the response of the instrument and the concentrations of a series of external standards, an external calibration curve can be obtained by using the conventional regression analysis. The sample concentration can then be determined by the external calibration curve. As used above and herein, "detection" (e.g.. of fondaparinux and/or impurities) in a sample comprises, in an exemplary embodiment, the recording of
chromatograms using the methods described herein (e.g., by use of HILIC-UPLC") and peak identification using a coupled techinque such as CAD or MS thereby confirming (detecting) the presence or absence of tbndaparinux and/or impurities in the sample.
III. Examples
[0040] T he following examples are presented to describe the invention in further detail. However, the present invention is by no means restricted to the specific embodiments described herein.
Instrument
10041] The instruments involved in UPLC-MS study are Ultimate 3000 (UPLC) and micrOTOF-Q Π™ (MS) which were manufactured by Thermo Fisher Dionex and Bruker Daltonics, respectively. The instruments involved in UPLC-CAD are ACQUITY UPLC® System and Thermo Scientific Dionex Ultra CAD which were manufactured by Waters Corporation and Thermo Fisher Dionex, respectively.
Parameters
[0042] The conditions for analysis are set forth below. [0043] 1. An Amide-HILiC type column is used as the analytical column for analyzing poly-sulfonated oligosaccharides.
[0044] 2. The concentration of ammonium formate used in the mobile phase is 100 mM or higher than 100 mM.
[0045] 3. The volume proportion of ammonium formate : acetonitrile in the mobile phase composition is in the range of 95% - 5% ; 5% - 95%.
[0046] 4. The range of flow rate used in the examples below is 0.4 mL/min - 1 niL/min
[0047] 5. The range of column temperatures used in the methods described herein is 10°C - 70°C
[0Θ48] 6. The range of nebulizaiion temperature of charged aerosol detec tor used in this method is 10°C - 30°C
[0049] 7. The concentration of testing sample is from 15 ,ug/rnL to 30 mg/mL. [0050] 8. The injection volume of testing sample is from 1 μ to 5 uL. Sample Preparation
[Θ051] The sample is dissolved in a mixture of water and acetonnitrile (1 :1 ; 30rag/mL).
Examples 1-10 Comparison of different types of HILiC columns and general LC conditions [0052] The sample prepared as above is analyzed by different types of HILIC columns as shown in Table 1. The chromatograms recorded using various columns are shown in Figures 1 (a)-- (b) and peak identification of Fondaparinux was confirmed by LC- 8.
Table 1
Figure imgf000011_0001
[00S3'| In majority of Examples 1 -10, the peak of Fondaparinux was found to be asymmetric with a poor separation from the impurities with one exception, the case of Waters BEH Amide column. The LC conditions for Waters BEH Amide were optimized and a typical chromatogram is shown in Figure 2, This study demonstrates that the amide type of HILIC column provides a relatively better choice for the analysis of this synthetic poly-sulfated pentasaccharides among various types of HILIC columns.
Examples lla~lld Effect of various salts
[0054] Three different salts, ammonium formate, pyridinium formate and ammonium acetate were compared. The analysis condition is shown in Table 2. The results are shown in Figure 3. Table 2 j Example ! 1 1 a l ib l i e j l id
pSalt 50 mM ammonium 100 mM 100 mM 1 50 mM
j formate ammonium pyridinium I ammonium
1 formate formate j acetate
[0055] The best chromatographic performance in terms of retention, selectivity and a low noise level baseline was the mobile phase containing ammonium formate salt, at both 50 mM and 100 mM concentration levels (Figure 3a and 3b, respectively). Pyridinium formate (Figure 3c) and ammonium acetate (Figure 3d) showed higher baseline noise and less retention for the analyte of interest. Based on the study, ammonium formate was chosen to be the salt additive in the mobile phase composition.
Examples 12a~12f Effect of salt concentrations
[0056] Mobile phase compositions containing various concentrations of ammonium formate salt were studied to optimize the LC conditions. The concentrations of ammonium formate for Examples 12a~12f are provided in Table 3. The representative chromatograms are shown in Figure 4.
Table 3
Figure imgf000012_0001
[0057] The impurity profile was found to be very similar for chromatograms obtained with 50 mM and 100 mM salt concentrations (Figures 4a and 4b). As the salt concentration increased, a small peak (marked with a dark triangle, see figures 4d, 4e and 4f), right before the main peak, Fondaparlnux, was observed. The resolution of this new peak from the main peak was further improved as the salt concentration increased from 1 0 mM to 200 mM of ammonium formate. In addition, it was clear that the bandwidth of the main peak narrowed as the salt concentration increased to 175 mM; no further improvement on resolution and peak shape was observed when the salt concentration was increased beyond 175 mM. Examples 13a- 13b Effect of solvent
[0058J Examples 13a and 13b use the mixtures of acetonitrile and acetone and acetonitrile respectively as the solvent of the mobile phase for analyzing Fondaparinux Sodium according to the present invention. Although the results shown in Figure 5 indicate no obvious difference in selectivity between acetonitrile system and mixture (acetonitrile and acetone) system, a higher back pressure was observed in the system comprising the acetone/acetonitrile mixture than in the acetonitrile system.
[0059] Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, one of skill in the art will appreciate that certain changes and modifications may be practiced within the scope of the appended claims. In addition, each reference provided herein is incorporated by reference in its entirety to the same extent as if each reference was indi vidually incorporated by reference. Where a conflict exists between the instant application and a reference provided herein, the instant application shall dominate.

Claims

WHAT IS CLAIMED IS; 1. A method for detecting and quantitating one or more poly-sulfated oligosaccharides in a sample, the method comprising: (a) subjecting said sample to chromatography on a. hydrophilic interaction ultra- performance liquid chromatography (HLLIC-UPLC) column coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS), wherein the stationary phase used in HILiC column is an amide-bonded stationary phase; and (b) determining the amount of poly-sulfated oligosaccharides in the sample. 2. The method of claim 1, wherein the mobile phase used in HILIC column comprises a salt. 3. The method of claim 2, wherein the salt is selected from ammonium formate, pyridinium formate and ammonium acetate. 4. The method of claim 3, wherein the salt is ammonium f ormate. S. The method of claim 3, wherein the salt is ammonium formate and is present in the mobile phase at a concentration of from about 50 mM to 300 mM. 6. The method of claim 5, wherein the concentration of ammonium formate in the mobile phase is from about 100 mM to 200 mM. 7. The method of claim 1, wherein the solvent of the mobile phase used in Hi LiC column is acetonitrile, acetone or a mixture of acetonitrile and acetone. 8. The method of claim 1, wherein the mobile phase used in HILIC column is acetonitrile. 9. The method of claim 1, wherein the poly-sulfated oligosaccharide is fondaparinux having the structure:
Figure imgf000015_0001
A method for detecting and quantitating fondaparinux in a sampl method comprising;
(a) subjecting said sample to chromatography on a hydrophiiic interaction ultra- performance liquid chromatography (HILIC-UPLC) column coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS), wherein the stationary phase used in H1LIC column is an amide-bonded stationary phase, the mobile phase used in said chromatography is acetonitriie, and the mobile phase comprises ammonium formate in a concentration of from about 100 mM to about 200 niM; and
(b) determining the amount of fondaparinux in the sample.
PCT/US2013/050147 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides WO2015005928A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CA2917460A CA2917460A1 (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides
CN201380078160.1A CN105431733B (en) 2013-07-11 2013-07-11 For detecting the analysis method of sulfated oligosaccharide
AU2013393832A AU2013393832B2 (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides
JP2016525337A JP6208866B2 (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides
PCT/US2013/050147 WO2015005928A1 (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides
KR1020167003059A KR20160030963A (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides
EP13888999.3A EP3019861A4 (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides
IL243405A IL243405A0 (en) 2013-07-11 2015-12-30 Analytical method for detecting sulfated oligosaccharides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2013/050147 WO2015005928A1 (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides

Publications (1)

Publication Number Publication Date
WO2015005928A1 true WO2015005928A1 (en) 2015-01-15

Family

ID=52280428

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/050147 WO2015005928A1 (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides

Country Status (8)

Country Link
EP (1) EP3019861A4 (en)
JP (1) JP6208866B2 (en)
KR (1) KR20160030963A (en)
CN (1) CN105431733B (en)
AU (1) AU2013393832B2 (en)
CA (1) CA2917460A1 (en)
IL (1) IL243405A0 (en)
WO (1) WO2015005928A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105628820A (en) * 2016-01-08 2016-06-01 东营天东制药有限公司 Fast detection method for free sulfate ion in production process of low molecular heparin
JP2017116421A (en) * 2015-12-24 2017-06-29 昭和電工株式会社 Method for separating and analyzing hydrophilic compounds
US9902971B2 (en) 2014-06-26 2018-02-27 Regeneron Pharmaceuticals, Inc. Methods for producing a mouse XY embryonic (ES) cell line capable of producing a fertile XY female mouse in an F0 generation
US11166915B2 (en) 2016-09-16 2021-11-09 Leukocare Ag Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
US11366086B2 (en) * 2017-09-06 2022-06-21 Shanghai Green Valley Pharmaceutical Co., Ltd. Method for determining weight-average molecular weight and content of soluble salt of acidic carbohydrates
US11510871B2 (en) 2016-09-16 2022-11-29 Leukocare Ag Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110709696B (en) * 2017-06-22 2022-01-04 昭和电工株式会社 Method for separating and analyzing mixture of oligonucleotides
CN109254101B (en) * 2017-07-13 2021-07-09 中国科学院大连化学物理研究所 Method for purifying and analyzing breast milk acid oligosaccharide
CN112005110B (en) * 2018-07-24 2022-11-29 深圳市海普瑞药业集团股份有限公司 Analysis method and application of dalteparin sodium nitrite degradation product
WO2020020145A1 (en) * 2018-07-26 2020-01-30 深圳市海普瑞药业集团股份有限公司 Method for analyzing sugar chain distribution of low molecular heparin and use thereof
CN111239311A (en) * 2018-11-28 2020-06-05 中国科学院大连化学物理研究所 Analysis method of acid sugar and acid sugar derivative in infant excrement
CN109633003A (en) * 2018-12-26 2019-04-16 成都普思生物科技股份有限公司 Radix Polygalae mouth mountain ketone III and 3,6 in a kind of measurement Radix Polygalae, the method for-two mustard acyl cane sugar contents
CN110161147A (en) * 2019-06-19 2019-08-23 北京三元食品股份有限公司 The high-throughput quantification measuring method of free oligosaccharides in cream
JP7487987B1 (en) 2023-12-21 2024-05-21 伊那食品工業株式会社 Analytical Method for Agro-oligosaccharides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090090856A1 (en) * 2007-06-01 2009-04-09 Russell Philip Grant Methods and systems for quantification of peptides and other analytes
US20090162938A1 (en) * 2005-11-08 2009-06-25 Suomen Punainen Risti,Veripalvelu Novel Carbohydrate Profile Compositions From Human Cells and Methods for Analysis and Modification Thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8696917B2 (en) * 2009-02-09 2014-04-15 Edwards Lifesciences Corporation Analyte sensor and fabrication methods
EP2306199A1 (en) * 2009-09-29 2011-04-06 Academisch Ziekenhuis Leiden Acting Under The Name Leiden University Medical Center Reductive amination and analysis of carbohydrates using 2-picoline borane as reducing agent
CN102101875A (en) * 2009-12-16 2011-06-22 中国科学院大连化学物理研究所 Method for purifying and separating oligosaccharides
AU2010332797B2 (en) * 2009-12-18 2015-05-28 Catalent Pharma Solutions Gmbh Pharmaceutical oral dosage form containing a synthetic oligosaccharide
MX2012007662A (en) * 2010-01-07 2012-08-23 Polymedix Inc Anti-heparin compounds.
CN102759596B (en) * 2012-07-09 2014-08-20 山东大学 Method for detecting low-molecular-weight heparin by combining ion pair reversed phase chronmatogaphy and mass spectrum

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090162938A1 (en) * 2005-11-08 2009-06-25 Suomen Punainen Risti,Veripalvelu Novel Carbohydrate Profile Compositions From Human Cells and Methods for Analysis and Modification Thereof
US20090090856A1 (en) * 2007-06-01 2009-04-09 Russell Philip Grant Methods and systems for quantification of peptides and other analytes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DESAI, U. R. ET AL.: "Substrate specificity of the heparin lyases from flavobacterium heparinum", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, vol. 306, no. 2, 1 November 1993 (1993-11-01), pages 461 - 468, XP024753614 *
PONNUSAMY, POOJA, REVERSE-PHASE ION-PAIRING ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY IN CHARACTERIZATION AND FINGERPRINTING OF DIVERSE SULFATED GLYCOSAMINOGLYCAN MIMETICS, May 2013 (2013-05-01), VIRGINIA COMMONWEALTH UNIVER ITY, pages 1 - 195, XP055290982 *
See also references of EP3019861A4 *
ZAIA, JOSEPH: "ON-LINE SEPARATIONS COMBINED WITH MS FOR ANALYSIS OF GLYCOSAMINOGLYCANS", MASS SPECTROMETRY REVIEWS, vol. 28, no. 2, 2009, pages 254 - 272, XP055165778 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9902971B2 (en) 2014-06-26 2018-02-27 Regeneron Pharmaceuticals, Inc. Methods for producing a mouse XY embryonic (ES) cell line capable of producing a fertile XY female mouse in an F0 generation
JP2017116421A (en) * 2015-12-24 2017-06-29 昭和電工株式会社 Method for separating and analyzing hydrophilic compounds
CN105628820A (en) * 2016-01-08 2016-06-01 东营天东制药有限公司 Fast detection method for free sulfate ion in production process of low molecular heparin
US11166915B2 (en) 2016-09-16 2021-11-09 Leukocare Ag Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
US11510871B2 (en) 2016-09-16 2022-11-29 Leukocare Ag Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation
US11366086B2 (en) * 2017-09-06 2022-06-21 Shanghai Green Valley Pharmaceutical Co., Ltd. Method for determining weight-average molecular weight and content of soluble salt of acidic carbohydrates

Also Published As

Publication number Publication date
AU2013393832B2 (en) 2017-11-30
KR20160030963A (en) 2016-03-21
EP3019861A1 (en) 2016-05-18
CA2917460A1 (en) 2015-01-15
JP6208866B2 (en) 2017-10-04
EP3019861A4 (en) 2017-02-22
CN105431733A (en) 2016-03-23
JP2016524166A (en) 2016-08-12
CN105431733B (en) 2019-01-22
AU2013393832A1 (en) 2016-02-04
IL243405A0 (en) 2016-02-29

Similar Documents

Publication Publication Date Title
AU2013393832B2 (en) Analytical method for detecting sulfated oligosaccharides
Barfi et al. Simplified miniaturized ultrasound-assisted matrix solid phase dispersion extraction and high performance liquid chromatographic determination of seven flavonoids in citrus fruit juice and human fluid samples: hesperetin and naringenin as biomarkers
Campillo et al. Dispersive liquid–liquid microextraction for the determination of macrocyclic lactones in milk by liquid chromatography with diode array detection and atmospheric pressure chemical ionization ion-trap tandem mass spectrometry
Sentkowska et al. Effects of the operation parameters on HILIC separation of flavonoids on zwitterionic column
Bengtsson et al. On‐line desalting and determination of morphine, morphine‐3‐glucuronide and morphine‐6‐glucuronide in microdialysis and plasma samples using column switching and liquid chromatography/tandem mass spectrometry
Prasanthi et al. Development and validation of RP-HPLC method for simultaneous estimation of rifampicin, isoniazid and pyrazinamide in human plasma
Li et al. Rapid determination of alkaloids in Macleaya cordata using ionic liquid extraction followed by multiple reaction monitoring UPLC–MS/MS analysis
US9441053B2 (en) Analytical method for detecting sulfated oligosaccharides
Salas et al. Hydrophilic interaction liquid chromatography coupled to high-resolution mass spectrometry to determine artificial sweeteners in environmental waters
Abdallah HPLC and densitometric TLC methods for simultaneous determination of gemifloxacin with some co-administered drugs in human plasma
Ito et al. Quantification of intact carboplatin in human plasma ultrafitrates using hydrophilic interaction liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study
Yaroshenko et al. Development and validation of a LC-MS/MS method for d-cycloserine determination in human plasma for bioequivalence study
Van Quekelberghe et al. Optimization of an LC-MS method for the determination of artesunate and dihydroartemisinin plasma levels using liquid-liquid extraction
Luan et al. Determination of Raddeanin A in rat plasma by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study
Yaroshenko et al. Chromatographic determination of sildenafil in blood plasma using spectrophotometric and mass-spectrometric detection
Neu et al. On-line solid-phase extraction high-performance liquid chromatography-tandem mass spectrometry for the quantitative analysis of tacrolimus in whole blood hemolyzate
Hewavitharana et al. Separation of highly charged compounds using competing ions with hydrophilic interaction liquid chromatography–Application to assay of cellular nucleotides
Wang et al. Application of solvent demulsification dispersive liquid–liquid microextraction for nicotine and cotinine measurement in human urine combined with hydrophilic interaction chromatography tandem mass spectrometry
Adamovics et al. Preparative liquid chromatography of pharmaceuticals using silica gel with aqueous eluents
Yadeghari et al. A microextraction liquid-chromatographic determination of aristolochic acid I in urine, flour, and aristolochiaceae fruit
Ahmed et al. Quantitative determination of azithromycin in human plasma by liquid chromatography mass spectrometry and its application in Pharmackokinetic study
Shamsipur et al. A manual shaking-enhanced, ultrasound-assisted dispersive liquid–liquid microextraction for the determination of betamethasone and dexamethasone: optimization using Response surface methodology
Wang et al. Identification of l‐carnitine and its impurities in food supplement formulations by online column‐switching liquid chromatography coupled with linear ion trap mass spectrometry
Suzuki et al. The internal standard diquat-d 4 causes errors in diquat analysis by LC–MS/MS
Huang et al. Development and validation of a method for the determination of nicotinic acid in human plasma using liquid chromatography-negative electrospray ionization tandem mass spectrometry and its application to a bioequivalence study

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201380078160.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13888999

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 243405

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2917460

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2016525337

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20167003059

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2013888999

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2013393832

Country of ref document: AU

Date of ref document: 20130711

Kind code of ref document: A